Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Viking Therapeutics, Inc. | VKTX | 9.72K | $379.06K |
COMPASS Pathways plc | CMPS | 15K | $212.25K |
BioCryst Pharmaceuticals, Inc. | BCRX | 16.76K | $167.56K |
ACADIA Pharmaceuticals Inc. | ACAD | 28.1K | $710.9K |
Hyperliquid Strategies Inc Common Stock | PURR | 30K | $236.11K |
Tarsus Pharmaceuticals, Inc. | TARS | 31.17K | $1.96M |
Arrowhead Pharmaceuticals, Inc. | ARWR | 38.28K | $3.12M |
First Tracks Biotherapeutics Inc | TRAX | 42.77K | $860.63K |
Solid Biosciences Inc. | SLDB | 42.96K | $429.13K |
Nyxoah S.A. | NYXH | 47.36K | $80.03K |
BridgeBio Pharma, Inc. | BBIO | 57.42K | $4.28M |
Immunic, Inc. | IMUX | 67.46K | $1.04M |
Praxis Precision Medicines, Inc. | PRAX | 72.84K | $24.39M |
Wave Life Sciences Ltd. | WVE | 85.28K | $495.51K |
Cue Biopharma, Inc. | CUE | 104.36K | $3.29M |
Amylyx Pharmaceuticals, Inc. | AMLX | 117.5K | $2.11M |
Enliven Therapeutics, Inc. | ELVN | 126.54K | $6.42M |
Harrow Health, Inc. | HROW | 135.78K | $5.77M |
Lexicon Pharmaceuticals, Inc. | LXRX | 164.67K | $395.22K |
Ultragenyx Pharmaceutical Inc. | RARE | 165.62K | $5.53M |